13 Matching Annotations
  1. Jul 2023
  2. Jun 2023
    1. Adjuvantradiotherapy ranging in dosage from 54 Gy to 62 Gy was administered to patients whoexhibited deep-seated, high-grade tumors that were larger than 5 cm

      Dosis y beneficio RT adyuvante TMVNP: * Dosis: 54-62 Gy en tumor profundo, alto grado, >5cm * Beneficio en SLE y SG a 5 años A 5 años: * SLE: 42% con RT vs 0% sin RT * SG: 65% con RT vs 38% sin RT

    1. used 45 Gy (25 fractions of 1.8 Gy) neoadjuvant radiotherapy to the primary site, followed by resection and adjuvant radiotherapy with the dose determined by the success of resection–10.8 Gy (6 fractions of 1.8 Gy) for microscopic residual disease R1 (cumulative dose 55. 8 Gy) or 19.8 Gy (11 fractions of 1.8 Gy) for gross residual disease/no resection (cumulative dose 64.8 Gy)

      RT neo: 45 Gy + RT PO: 10.8Gy/6fx en R1, 19.8Gy/11fx en R2

  3. May 2022
    1. Because of the very close spatial proximity of radiosensitive gastrointestinal structures and spatial instability during repeated fractions (especially in the case of the small intestine), the dose 35 Gy in five fractions was most frequently prescribed, and the median biological equivalent dose (BED10Gy) was 60 Gy (in the range of 48–112 Gy).

      SBRT ganglios: 35 Gy en 5 fracciones Dosis de restricción para 5 sesiones.

  4. Apr 2022